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Edited by Sandro SonninoAbstract Dystroglycan is a central component of dystrophin–
glycoprotein complex that links extracellular matrix and cyto-
skeleton in skeletal muscle. Although dystrophic chicken is well
established as an animal model of human muscular dystrophy,
the pathomechanism leading to muscular degeneration remains
unknown. We show here that glycosylation and laminin-binding
activity of a-dystroglycan (a-DG) are defective in dystrophic
chicken. Extensive glycan structural analysis reveals that
Galb1-3GalNAc and GalNAc residues are increased while
Siaa2-3Gal structure is reduced in a-DG of dystrophic chicken.
These results implicate aberrant glycosylation of a-DG in the
pathogenesis of muscular degeneration in this model animal of
muscular dystrophy.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The dystroglycan complex is composed of two proteins, a-
and b-dystroglycan (a- and b-DG), which are encoded by a
single gene and cleaved by posttranslational processing [1].
a-DG is a highly glycosylated extracellular peripheral mem-
brane protein and binds to several extracellular matrix
(ECM) proteins including laminin, agrin, and perlecan [2–4].
In turn, the transmembrane protein b-DG anchors a-DG at
the extracellular surface of the plasma membrane, while its
cytoplasmic domain interacts with dystrophin, a large cyto-
plasmic protein that binds to F-actin [5]. Thus, the DG com-
plex plays a crucial role to stabilize the plasma membrane by
acting as an axis through which the ECM is tightly linked to
the cytoskeleton.Abbreviations:DG, dystroglycan; DGC, dystrophin–glycoprotein com-
plex
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doi:10.1016/j.febslet.2005.03.033Recently, primary mutations in the genes encoding putative
glycosyltransferases have been identiﬁed in several types of
congenital muscular dystrophies including Fukuyama-type
congenital muscular dystrophy, muscle–eye–brain disease,
Walker–Warburg syndrome, congenital muscular dystrophy
1C (MDC1C) and 1D (MDC1D) [6–10]. Because glycosylation
and laminin-binding activity of a-DG are defective in these dis-
eases [11], they are collectively called a-dystroglycanopathy
[12]. However, the precise oligosaccharide structures defective
in a-dystroglycanopathy have not been elucidated.
Muscular dystrophy in chicken was ﬁrst described in 1956
[13]. Although dystrophic chicken has been established as an
animal model of muscular dystrophy, the primary mutation
has not yet been identiﬁed [14] and the pathomechanism lead-
ing to muscle cell degeneration remains unknown. We demon-
strate here that glycosylation and laminin-binding activity of
a-DG are defective in the skeletal muscle of dystrophic chick-
en. Extensive glycan structural analysis reveals that, compared
to control chicken, the amount of Galb1-3GalNAc and Gal-
NAc residues are increased, whereas Siaa2-3Gal structure is
reduced in a-DG of dystrophic chicken.2. Materials and methods
2.1. Antibodies
Mouse monoclonal antibody against sugar chain moiety of a-DG
(IIH6) and sheep polyclonal antibody against core protein of a-DG
(sheep anti-a-DG) were described previously [2,15]. Mouse monoclo-
nal antibody against sugar chain moiety of a-DG (IVA4-1) was ob-
tained from Upstate Biotechnology. Mouse monoclonal antibody
against b-DG (8D5), b-sarcoglycan (5B1) and c-sarcoglycan (21B5)
were kind gifts from Dr. L.V.B. Anderson (Newcastle General Hospi-
tal). Mouse monoclonal anti-dystrophin (MANDRA 1) and aﬃnity
isolated rabbit anti-laminin were obtained from Sigma. Mouse mono-
clonal anti-dystrobrevin was purchased from BD Biosciences.
2.2. Lectin chromatography
Dystrophic chicken used in this study is New Hampshire, line 413,
the colony of which is maintained homozygously. Line GSN/1, was
used as a control. Pectoralis muscle of dystrophic and control chicken
of 3 months of age were used. Skeletal muscle was disrupted with a
polytron followed by Daunce homogenization and incubation in
50 mM Tris–HCl, pH 7.4, 500 mM NaCl, 1% Triton X-100, 0.6 lg/
ml pepstatin A, 0.5 lg/ml leupeptin, 0.5 lg/ml aprotinin, 0.75 mM ben-
zamidine, and 0.1 mM PMSF. The extract was incubated with lectinblished by Elsevier B.V. All rights reserved.
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(Con A), peanut agglutinin (PNA), Vicia villosa agglutinin isolectin
B4 (VVA-B4), Maackia amurensis lectin (MAM) and lentil lectin
(LCA). Bound proteins were eluted by boiling the beads in sample buf-
fer (65 mM Tris–HCl, pH 6.9, 3% SDS, 1% b-mercaptoethanol,
115 mM sucrose, and 0.0004% bromophenol blue) and the eluates were
analyzed by Western blotting using sheep anti-a-DG.
2.3. Miscellaneous
Chemical deglycosylation was described previously [2]. Sialidase
digestion was performed using sialidase from Clostridium perfringens
(Roche) according to the procedure described elsewhere [16]. Immuno-
ﬂuorescent microscopic analysis, Western blotting and blot overlay as-
say were performed as described elsewhere [11]. The amount of
glycosidically bound sialic acid was compared by periodate–resorcinol
method [17] and statistical signiﬁcance was evaluated by t test. Solid-
phase assay was performed as previously mentioned [11] except that
WGA eluates were coated on 96 wells EIA/RIA plates (Coaster) after
measuring the band intensity of a-DG on Western blots so that each
well contained the same amount of a-DG.3. Results
3.1. Decreased immunoreactivity of a-DG in the skeletal muscle
of dystrophic chicken
We ﬁrst performed immunoﬂuorescent microscopic analysis.
The immunoreactivity of a-DG revealed by antibody against
sugar chain moiety of a-DG was signiﬁcantly decreased in dys-
trophic chicken, whereas the immunoreactivity of a-DG was
indistinguishable between control and dystrophic chicken
when detected by antibody against core protein of a-DG.
The other components of dystrophin–glycoprotein complex
(DGC) were normally expressed in dystrophic chicken (Fig.
1). Consistent with the immunoﬂuorescent analysis, WesternFig. 1. Immunoreactivity of a-dystroglycan is reduced in the skeletal muscl
moiety. Expression and localization of each component of the DGC were an
DG, as revealed by antibody against sugar chain moiety of a-DG (IIH6), is
protein is not altered. DG, dystroglycan; LAM, laminin; SG, sarcoglycan; Dblotting with antibody against sugar chain moiety of a-DG
demonstrated reduced immunoreactivity of a-DG in dystro-
phic chicken (Fig. 2). In addition, a-DG of dystrophic chicken
migrated at 160 kD, faster than that of control which migrated
at 200 kD (Fig. 2). The expression and molecular mass of the
other components of the DGC were not altered (Fig. 2).
3.2. Altered glycosylation of a-DG in the skeletal muscle of
dystrophic chicken
The results described above raise the possibility that the
glycosylation, rather than expression, of a-DG in dystrophic
chicken may be altered. In order to test this possibility,
a-DG was enriched by WGA chromatography and chemically
deglycosylated with triﬂuoromethanesulfonic acid. Similar
to the antibody against sugar chain moiety of a-DG, anti-
body against core protein of a-DG recognized a-DG species
migrating around 200 and 160 kD in control and dystrophic
chicken, respectively (Fig. 3, deglycosylation ). In addition,
however, the anti-core protein antibody also detected a-DG
species with a lower molecular mass of 110 kD in control and
70–120 kD in dystrophic chicken (Fig. 3, deglycosylation ).
In this report, we tentatively call the larger and smaller
a-DG species as L-a-dystroglycan (L-a-DG) and S-a-dystro-
glycan (S-a-DG), respectively. Upon chemical deglycosyla-
tion, the molecular mass of a-DG was reduced to 55 kD
both in control and dystrophic chicken equally, eliminating
the diﬀerence in molecular mass (Fig. 3, deglycosylation +).
These data indicate that a-DG is aberrantly glycosylated in
the skeletal muscle of dystrophic chicken. We also examined
various tissues of dystrophic chicken to see if defective glyco-
sylation of a-DG was present. Western blot analysis using
antibody against core protein of a-DG demonstrated ae of dystrophic chicken when probed by antibody against sugar chain
alyzed by immunoﬂuorescent microscopy. The immunoreactivity of a-
reduced in dystrophic chicken. However, the expression of a-DG core
BV, dystrobrevin; DYS, dystrophin. Bar indicates 100 lm.
Fig. 2. The molecular mass of a-DG is decreased in the skeletal muscle
of dystrophic chicken. Western blotting was performed to examine the
expression of a-DG using whole skeletal muscle homogenates. The
amount of protein loaded for each lane was normalized using myosin
heavy chain as internal standard (arrowhead in the panel CB). a-DG in
dystrophic chicken migrates faster than that in control and the
immunoreactivity of a-DG is decreased in dystrophic chicken using
antibody against sugar chain moiety of a-DG (IIH6). The expression
of other components of the DGC is not altered. CB, Coomassie blue
staining; DG, dystroglycan; LAM, laminin; SG, sarcoglycan.
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muscle, but not in other tissues including brain, peripheral
nerve, kidney, spleen and liver (data not shown), indicatingFig. 3. Deglycosylation eliminates the diﬀerence in molecular mass of
a-DG between control and dystrophic chicken. a-DG was enriched by
WGA chromatography and chemically deglycosylated with triﬂuo-
romethanesulfonic acid. Antibody against core protein of a-DG
recognizes a-DG species with higher molecular mass (L-a-DG), which
are also detected by antibody against sugar chain moiety of a-DG
(VIA4-1). In addition, the anti-core protein of a-DG recognizes a-DG
species with lower molecular mass (S-a-DG). After deglycosylation,
the molecular mass of a-DG decreases to 55 kD in both control and
dystrophic chicken equally (deglycosylation +).that glycosylation of a-DG was also altered in the cardiac
muscle of dystrophic chicken.
3.3. Laminin-binding activity of a-DG is decreased in the skeletal
muscle of dystrophic chicken
Blot overlay assays demonstrated that the binding of lami-
nin 1 and 2 to a-DG was greatly reduced in dystrophic chicken
(Fig. 4A). Notably, both laminin 1 and 2 bound to L-a-DG,
but not S-a-DG (Fig. 4A). The band intensity of S-a-DG
and L-a-DG was measured and the ratio of S-a-DG against
total a-DG (intensity of S-a-DG/intensity of S-a-DG + L-a-
DG) was calculated. The ratio of S-a-DG was 16.8 ± 4.5% in
control versus 40.9 ± 4.1% in dystrophic chicken (Fig. 4B),
indicating that many more a-DG molecules in dystrophic
chicken lack the laminin-binding activity than control. Next,
we performed quantitative solid-phase assay. The total lami-
nin-binding activity was signiﬁcantly decreased in the skeletal
muscle of dystrophic chicken (Fig. 4C).
3.4. Glycosylation defects of dystrophic chicken a-DG analyzed
by lectin chromatography
To investigate the change in glycan structure of a-DG in dys-
trophic chicken, we performed a set of lectin chromatographies.Fig. 4. Laminin-binding activity of a-DG is decreased in the skeletal
muscle of dystrophic chicken. (A) Equal amount of DG was
transferred to PVDF membranes as revealed by Western blotting for
a-DG and b-DG. Blot overlay assays demonstrate that the binding of
both laminin 1 and 2 to a-DG is substantially decreased in dystrophic
chicken. Both laminin 1 and 2 bind to L-a-DG, but not S-a-DG. Lam
1, laminin 1; Lam 2, laminin 2. (B) The band intensity of L-a-DG and
S-a-DG was measured and the ratio of S-a-DG against total a-DG
was calculated. The ratio of S-a-DG is signiﬁcantly higher in
dystrophic chicken. \P < 0.003. (C) Solid-phase assay reveals that
laminin-binding activity is signiﬁcantly reduced in the skeletal muscle
of dystrophic chicken.
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whereas LCA had no signiﬁcant interaction with any a-DG
species (Fig. 5A). In sharp contrast, MAM bound L-a-DG in
control, while it interacted only weakly with a-DG in dystro-
phic chicken (Fig. 5A), indicating that Siaa2-3Gal moieties
are profoundly reduced in a-DG of dystrophic chicken. Inter-
estingly, PNA bound to a fraction of S-a-DG in dystrophic
chicken, while no binding to a-DG occurred in control (Fig.
5B, sialidase ). VVA-B4 bound weakly to S-a-DG in control,
whereas it strongly interacted with L-a-DG and S-a-DG in dys-Fig. 5. Glycosylation of a-DG is altered in the skeletal muscle of
dystrophic chicken. (A) a-DG was extracted using Triton X-100 and
applied to lectin chromatography. The bound a-DG was visualized by
Western blotting using antibody against core protein of a-DG. Con-A
binds most of the a-DG species, while LCA does not interact with any
a-DG species signiﬁcantly. MAM strongly binds only to L-a-DG in
control. (B) The Triton X-100 extracts were applied to PNA or VVA-
B4 chromatography with or without prior digestion by sialidase.
Without sialidase treatment, PNA binds S-a-DG in dystrophic
chicken, while it does not interact with a-DG in control (sialidase
). VVA-B4 binds S-a-DG in control only weakly, while it interacts
strongly with both L- and S-a-DG in dystrophic chicken (sialidase ).
With sialidase digestion, both PNA and VVA-B4 bind extensively to L-
a-DG and S-a-DG in dystrophic chicken compared to control
(sialidase +). (C) Quantiﬁcation of sialic acid by periodate–resorcinol
method reveals that the amount of glycosidically bound sialic acids in
the skeletal muscle of dystrophic chicken is signiﬁcantly less than that
of control chicken. \P < 0.001.trophic chicken. Because the reactivity of these lectins are
known to be severely decreased when sialic acids are attached
to non-reducing termini of their binding sugar chain moieties
[18], we enzymatically removed sialic acids by sialidase and re-
peated the experiments. After sialidase digestion, both S-a-DG
and L-a-DG extensively interacted with PNA in dystrophic
chicken, whereas only a small amount of S-a-DG was recov-
ered in control. These results indicate that Galb1-3GalNAc
moieties are much more abundant on a-DG in dystrophic
chicken than that in control (Fig. 5B, sialidase +). Similar result
was obtained with VVA-B4, indicating that GalNAc structures
are much more abundant on a-DG of dystrophic chicken
(Fig. 5B, sialidase +). The amount of glycosidically bound
sialic acids quantiﬁed by periodate–resorcinol method was sub-
stantially reduced in dystrophic chicken (Fig. 5C), which is
consistent with the result of MAM lectin chromatography.4. Discussion
The mucin-like domain of a-DG is heavily glycosylated by
O-linked glycans [19], with the sugar chain moieties constitut-
ing up to two-thirds of its total molecular mass [1,2]. The
antibody against sugar chain moiety of a-DG detected only
L-a-DG, while anti-a-DG core protein detected both L-a-
DG and S-a-DG (Figs. 2 and 3), indicating diverse glycosyla-
tion of a-DG in vivo. Notably, laminin bound to L-a-DG, but
not to S-a-DG, in both control and dystrophic chicken (Fig.
4), indicating that the interaction of laminin with a-DG is
strictly regulated through glycosylation of a-DG and that a
fraction of a-DG does not possess the sugar chain moieties
necessary for the binding of laminin in vivo. Furthermore,
the ratio of non-laminin-binding a-DG (S-a-DG) is greatly in-
creased in dystrophic chicken compared to control (Fig. 4). It
would be intriguing to postulate that the increase of non-lam-
inin-binding a-DG may contribute to the dystrophic pheno-
type by exerting a dominant negative eﬀect in dystrophic
chicken, where non-laminin-binding a-DG competes with lam-
inin-binding a-DG for the cytoskeletal linkage via dystrophin.
Consistent with this hypothesis, we have observed that adeno-
virus mediated gene transfer of non-laminin-binding a-DG
constructs results in the degeneration of skeletal muscle in mice
(Saito and Campbell, unpublished observation).
The results of lectin chromatography indicate that, com-
pared to control chicken, the amount of Galb1-3GalNAc
and GalNAc residues are increased signiﬁcantly while Siaa2-
3Gal structure is severely decreased in a-DG of dystrophic
chicken (Fig. 5). The reduction in the amount of sialic acids
was conﬁrmed by periodate–resorcinol sialic acid assay (Fig.
5). However, a-DG appears to be hyposialylated rather than
asialylated (Fig. 5C). We have reported recently that hyposial-
ylation of a-DG alone is not enough to abolish its laminin-
binding activity in vivo [20]. It remains to be determined if
hyposialylation in dystrophic chicken reﬂects the reduction
of the sialyl O-mannosyl glycan, Sia2-3Galb1-4GlcNAcb1-
2Man-Ser/Thr, implicated in the binding of laminin [21,22].
Pavoni et al. [23] reported recently that antibody against C-
terminal portion of a-DG core protein detected a-DG with
molecular mass of 109 kD in the skeletal muscle of normal
chicken. Our S-a-DG may correspond to this small a-DG, as
judged by molecular mass. Pavoni et al. further postulated that
this 109 kD a-DG might be a partially glycosylated form of
F. Saito et al. / FEBS Letters 579 (2005) 2359–2363 2363a-DG. In the present study, we provided clear evidence of ac-
tual alteration of glycosylation of this small a-DG molecule
(Figs. 3 and 5). The molecular mass of a-DG in the skeletal
muscle of normal chicken was reported to change during devel-
opment [24]. It would be thus interesting to see if the molecular
mass of a-DG in the skeletal muscle of dystrophic chicken also
changes during development by future studies.
In conclusion, we have demonstrated altered glycosylation
and decreased laminin-binding activity of a-DG in chicken
muscular dystrophy. Furthermore, we have demonstrated that
Siaa2-3Gal structure is reduced, while Galb1-3GalNAc and
GalNAc moieties are increased on a-DG of this animal model
of muscular dystrophy. These data would contribute to further
understand the molecular mechanism of muscular degenera-
tion caused by disturbed glycosylation of a-DG in human
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